GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients [Meeting Abstract]

Peled, N.Gillis, R.Kilickap, S.Froesch, P.Orlov, S.Filippova, E.Demirci, U.2024-06-122024-06-1220211556-08641556-1380https://hdl.handle.net/20.500.14551/23671[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessROS1(+)ALK(+)LorlatinibGLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients [Meeting Abstract]Conference Object163S656S656Q1WOS:000631349602018